Summary
Updated Aug 31, 2026
Simrat Randhawa is EVP, Head of R&D of Dianthus Therapeutics, Inc. /DE/ (DNTH). 5 SEC Form 4 filings on record going back to 2025, most recently on 2 June 2026. Most recent open-market trade: sold $380K of DNTH on 2 June 2026. Lifetime open-market sales: $12.54M.
Recent Transactions
20Every recent SEC Form 4 transaction Simrat Randhawa has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Simrat Randhawa go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. 34 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Simrat Randhawa files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marino Garcia - $27.96M of DNTH open-market activity in the last 12 months
- Ryan Savitz - $14.99M of DNTH open-market activity in the last 12 months
- Adam M. Veness - $4.63M of DNTH open-market activity in the last 12 months
- Edward Carr - $3.56M of DNTH open-market activity in the last 12 months
- Paula Soteropoulos - $2.25M of DNTH open-market activity in the last 12 months
- Anne McGeorge - $845K of DNTH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Simrat Randhawa?
Simrat Randhawa is a corporate insider, tracked as EVP, Head of R&D of Dianthus Therapeutics, Inc. /DE/ (DNTH). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Simrat Randhawa submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Simrat Randhawa been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($12.54M) across all tracked filings.
Where can I see all of Simrat Randhawa's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Simrat Randhawa and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial